Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CPH/GMAB stock hub

CPH/GMAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/GMABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

100.8B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/GMAB

In the news

Latest news · CPH/GMAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.2

P25 14.6P50 19.5P75 24.2

Trailing P/E19.3

P25 11.8P50 20.8P75 32.9

ROE15

P25 -4.6P50 11.3P75 24.2

ROIC10.7

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/GMAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	2,973
Employees Change	339%
Employees Change Percent	12.87
Enterprise value	DKK 125.6B
Exchange	Copenhagen Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	DK0010272202
Last refreshed	2026-05-10
Market cap	DKK 100.8B
Price	DKK 1,642
Price currency	DKK
Rev Per Employee	8,188,777.58x
Sector	Healthcare
Sic	2836
Symbol	cph/GMAB
Website	https://www.genmab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.28%
EV Earnings	23.6x
EV/EBIT	15.05x
EV/EBITDA	14.38x
EV/FCF	22.22x
EV/Sales	4.97x
FCF yield	5.61%
Forward P/E	20.16x
P/B ratio	2.74x
P/E ratio	19.32x
P/S ratio	3.99x
PE Ratio10 Y	43.38x
PE Ratio3 Y	21.58x
PE Ratio5 Y	32.49x
PEG ratio	1.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.99%
EBITDA Margin	34.09%
FCF margin	22.35%
Gross margin	93.31%
Gross Profit	DKK 23.6B
Gross Profit Growth	18.37%
Gross Profit Growth Q	23.48%
Gross Profit Growth3 Y	17.93%
Gross Profit Growth5 Y	16.39%
Net Income	DKK 5.3B
Net Income Growth	-27.73%
Net Income Growth Q	-72.82%
Net Income Growth Years	0%
Net Income Growth3 Y	2.7%
Net Income Growth5 Y	-1.41%
Pretax Margin	26.51%
Profit Margin	21.05%
Profit Per Employee	DKK 1.7M
Profitable Years	13
ROA	8.48
Roa5y	10.27
ROCE	11.49
ROE	14.96
Roe5y	18.28
ROIC	10.72
Roic5y	66.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.62%
Cagr15y	25.41%
Cagr1y	20.32%
Cagr20y	10.69%
Cagr3y	-15.6%
Cagr5y	-6.48%
EPS Growth	-25.81
EPS Growth Q	-72.79
EPS Growth Years	0
EPS Growth3 Y	4.5
EPS Growth5 Y	-0.38
FCF Growth	-24.76%
FCF Growth3 Y	-1.18%
FCF Growth5 Y	0.36%
OCF Growth	-24.46%
OCF Growth Q	-98.96%
OCF Growth10 Y	32.34%
OCF Growth3 Y	-1.94%
OCF Growth5 Y	0.04%
Revenue Growth	20.66x
Revenue Growth Q	25.32x
Revenue Growth Years	0x
Revenue Growth3 Y	20.68x
Revenue Growth5 Y	18.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.41
Assets	DKK 80.2B
Cash	DKK 9.9B
Current Assets	DKK 16.3B
Current Liabilities	DKK 7.5B
Debt	DKK 34.7B
Debt EBITDA	DKK 3.97
Debt Equity	DKK 0.94
Debt FCF	DKK 6.14
Equity	DKK 36.8B
Interest Coverage	7.66
Liabilities	DKK 43.4B
Long Term Assets	DKK 63.9B
Long Term Liabilities	DKK 35.9B
Net Cash	DKK -24.8B
Net Cash By Market Cap	DKK -24.61
Net Debt EBITDA	DKK 2.88
Net Debt Equity	DKK 0.67
Net Debt FCF	DKK 4.39
Tangible Book Value	DKK -23.5B
Tangible Book Value Per Share	DKK -382
WACC	6.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.18
Inventory Turnover	15.82
Net Working Capital	DKK 1.1B
Quick ratio	2.17
Working Capital	DKK 9B
Working Capital Turnover	DKK 10.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	72.7%
1Y total return	20.3%
200-day SMA	1,842
3Y total return	-39.89%
50-day SMA	1,741
50-day SMA vs 200-day SMA	50under200
5Y total return	-28.47%
All Time High	3,327
All Time High Change	-50.66%
All Time High Date	2022-12-05
All Time Low	22.1
All Time Low Change	7,327.6%
All Time Low Date	2002-12-03
ATR	59.52
Beta	0.7
Beta1y	0.99
Beta2y	0.91
Ch YTD	-19.02
High	1,714
High52	2,257
High52 Date	2026-01-14
High52ch	-27.27%
Low	1,546
Low52	1,204.5
Low52 Date	2025-05-12
Low52ch	36.28%
Ma50ch	-5.71%
Price vs 200-day SMA	-10.88%
RSI	38.37
RSI Monthly	44.57
RSI Weekly	39.41
Sharpe ratio	0.46x
Sortino ratio	0.83
Total Return	2.55%
Tr YTD	-19.02
Tr15y	2,884.55%
Tr1m	-6.28%
Tr1w	-3.1%
Tr3m	-16.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 8.3B
Operating Income Growth	18.4
Operating Income Growth Q	19.68
Operating Income Growth3 Y	12.44
Operating Income Growth5 Y	3.72
Operating margin	32.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,664,302%
Net Borrowing	34,364,968,000
Shares Insiders	1.18%
Shares Institutions	60.68%
Shares Out	61,391,058
Shares Qo Q	1.17%
Shares Yo Y	-2.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 4.7B
Average Volume	137,792.4x
Bv Per Share	600
CAPEX	DKK -194.5M
Ch10y	72.7
Ch15y	2,884.5
Ch1m	-6.28
Ch1w	-3.1
Ch1y	20.3
Ch20y	661.7
Ch3m	-16.16
Ch3y	-39.89
Ch5y	-28.47
Ch6m	-11.15
Change	-6.65%
Change From Open	-3.58
Close	1,758.5
Days Gap	-3.18
Depreciation Amortization	272,637,200
Dollar Volume	1,008,422,695
Earnings Date	2026-05-07
EBIT	DKK 8.3B
EBITDA	DKK 8.6B
EPS	DKK 84.98
F Score	4
FCF	DKK 5.7B
FCF EV Yield	4.5x
FCF Per Share	DKK 92.07
Financing CF	29,980,036,250
Fiscal Year End	December
Founded	1,998
Goodwill	2,250,842,000
Graham Number	1071.0799
Graham Upside	-34.75
Income Tax	DKK 1.4B
Investing CF	-36,358,491,530
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	DKK 425
Lynch Upside	-74.12
Ma150	1,917.2
Ma150ch	-14.38%
Ma20	1,742.9
Ma20ch	-5.82%
Net CF	-635,252,660
Next Earnings Date	2026-08-06
Open	1,702.5
P FCF Ratio	17.83
P OCF Ratio	17.24
Position In Range	56.85
Ppne	1,680,206,000
Price Date	2026-05-08
Price EBITDA	DKK 11.69
Relative Volume	4.81x
Revenue	25,286,945,170x
SBC By Revenue	3.9x
Share Based Comp	985,289,840
Tax By Revenue	5.46x
Tax Rate	20.6%
Tr20y	661.72%
Tr6m	-11.15%
Volume	614,330
Z Score	2.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/GMAB pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/GMAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/GMAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+60.7%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.6%

Negative means the company is buying back shares.

Technical

CPH/GMAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.4

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/GMAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/GMAB stock rating?

cph/GMAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/GMAB analysis?

The full report lives at /stocks/cph/GMAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/GMAB?

The latest report frames cph/GMAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/GMAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.